Jefferies raised the firm’s price target on Check Point (CHKP) to $250 from $235 and keeps a Buy rating on the shares. The company’s billings growth accelerated to 11% against consensus of 7%, while its new CEO Zafrir’s vision impressed with a clear focus on go-to-market refinement, the analyst tells investors in a research note. While sales leadership changes may create near-term hiccups in execution, Check Point’s FY25 revenue guidance feels “overly prudent” when considering billings and RPO strength, along with the company’s product refresh dynamics, the firm added.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CHKP:
- Check Point price target raised to $230 from $200 at Barclays
- Check Point price target raised to $250 from $220 at Truist
- Check Point price target raised to $208 from $185 at Evercore ISI
- Check Point price target raised to $240 from $200 at Raymond James
- Check Point sees FY25 adjusted EPS $9.60-$10.20, consensus $9.93.